Orthopediatrics (KIDS) Capital Expenditures (2016 - 2026)
Orthopediatrics' (KIDS) quarterly Capital Expenditures came in at $1.8 million in Q1 2026, down 58.36% year-on-year from $4.2 million in Q1 2025, and up 116.74% on a QoQ basis from -$10.5 million in Q4 2025.
Orthopediatrics (KIDS) Capital Expenditures (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of Capital Expenditures data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 58.36% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was -$2.5 million, a 120.51% decrease from a year earlier, with the FY2024 full-year figure at $14.3 million, up 2512.27% from the prior year.
- Capital Expenditures for Q1 2026 stood at $1.8 million, up from -$10.5 million in the prior quarter.
- Over the last five years, Capital Expenditures for KIDS reached as high as $6.7 million in Q2 2024 and fell as low as -$10.6 million in Q4 2022.
- Historically, Capital Expenditures has averaged $1.0 million across 5 years, with a median of $3.1 million in 2025.
- Across the five-year window, Capital Expenditures soared 205.39% in 2022 and slumped 3911.83% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at -$10.6 million in 2022, then gained by 5.09% to -$10.0 million in 2023, then jumped by 97.38% to -$262000.0 in 2024, then slumped by 3911.83% to -$10.5 million in 2025, then jumped by 116.74% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $1.8 million in Q1 2026, -$10.5 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthopediatrics | 443.38 Mn | 429.14 Mn | 43.39 Mn | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | -10.51 Mn |
| Dec 31, 2025 | -10.51 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Dec 31, 2024 | -262,000.00 |
| Dec 31, 2024 | -262,000.00 |
| Sep 30, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Mar 31, 2024 | 6.46 Mn |
| Mar 31, 2024 | 6.46 Mn |
| Sep 30, 2023 | -10.02 Mn |
| Sep 30, 2023 | -10.02 Mn |